19-3585647-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_133261.3(GIPC3):āc.50C>Gā(p.Ala17Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000439 in 1,206,654 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_133261.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GIPC3 | NM_133261.3 | c.50C>G | p.Ala17Gly | missense_variant | 1/6 | ENST00000644452.3 | NP_573568.1 | |
GIPC3 | NM_001411144.1 | c.50C>G | p.Ala17Gly | missense_variant | 1/6 | NP_001398073.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GIPC3 | ENST00000644452.3 | c.50C>G | p.Ala17Gly | missense_variant | 1/6 | NM_133261.3 | ENSP00000493901 | P1 | ||
GIPC3 | ENST00000644946.1 | c.50C>G | p.Ala17Gly | missense_variant | 1/6 | ENSP00000495068 |
Frequencies
GnomAD3 genomes AF: 0.0000596 AC: 9AN: 150982Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.0000417 AC: 44AN: 1055672Hom.: 0 Cov.: 30 AF XY: 0.0000497 AC XY: 25AN XY: 503490
GnomAD4 genome AF: 0.0000596 AC: 9AN: 150982Hom.: 0 Cov.: 31 AF XY: 0.0000407 AC XY: 3AN XY: 73696
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 228698). This variant has not been reported in the literature in individuals affected with GIPC3-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 17 of the GIPC3 protein (p.Ala17Gly). - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 08, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 04, 2015 | Variant classified as Uncertain Significance - Favor Benign. The p.Ala17Gly vari ant in GIPC3 has not been previously reported in individuals with hearing loss a nd was absent from large population studies. Computational prediction tools and conservation analyses suggest that the p.Ala17Gly variant may not impact the pro tein, though this information is not predictive enough to rule out pathogenicity . In summary, while the clinical significance of the p.Ala17Gly variant is unce rtain, conservation and computational data suggest that it is more likely to be benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at